Advertisement
Screener

AYTU BIOPHARMA, INC (AYTU) Interest Expense

2.8 / 5 stars · 68/120 Roast Me

AYTU BIOPHARMA, INC Interest Expense

AYTU BIOPHARMA, INC (AYTU) reported Interest Expense of $751.54 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2020-11-12

  • AYTU BIOPHARMA, INC interest expense for the quarter ending 2020-09-30 was $751.54K, a 284.64% increase year-over-year.
  • AYTU BIOPHARMA, INC interest expense for the quarter ending 2020-06-30 was $1.43M, a 942.89% increase year-over-year.
  • AYTU BIOPHARMA, INC interest expense for the quarter ending 2020-03-31 was $538.86K, a 176.76% increase year-over-year.
  • AYTU BIOPHARMA, INC interest expense for the quarter ending 2019-12-31 was $446.96K, a 250.37% increase year-over-year.
  • AYTU BIOPHARMA, INC interest expense for fiscal 2020 was $2.61M, a 386.74% increase from fiscal 2019.
  • AYTU BIOPHARMA, INC interest expense for fiscal 2019 was $535.50K, a 28.55% decline from fiscal 2018.
  • AYTU BIOPHARMA, INC interest expense for fiscal 2018 was $749.42K, a 70.43% decline from fiscal 2017.
  • AYTU BIOPHARMA, INC interest expense for fiscal 2017 was $2.53M, a 53.85% decline from fiscal 2016.
Period endInterest Expense 3 monthInterest Expense 3 month as first filedInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 monthInterest Expense 81 monthInterest Expense 84 monthInterest Expense 87 monthInterest Expense 90 monthInterest Expense 93 monthInterest Expense 96 monthInterest Expense 99 monthInterest Expense 102 monthInterest Expense 105 monthInterest Expense 108 monthInterest Expense 111 month
2020-09-30$751.54K
10-Q · filed 2020-11-12
$2.18M
derived: sum of 2 quarters · filed 2020-11-12
$2.72M
derived: sum of 3 quarters · filed 2020-11-12
$3.16M
derived: sum of 4 quarters · filed 2020-11-12
2020-06-30$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06
$1.96M
derived: sum of 2 quarters · filed 2020-10-06
$2.41M
derived: sum of 3 quarters · filed 2020-10-06
$2.61M
10-K · filed 2020-10-06
2020-03-31$538.86K
10-Q · filed 2020-05-15
$985.82K
derived: sum of 2 quarters · filed 2020-05-15
$1.18M
10-Q · filed 2020-05-15
$1.32M
derived: sum of 4 quarters · filed 2020-11-12
2019-12-31$446.96K
10-Q · filed 2020-02-14
$642.34K
10-Q · filed 2020-02-14
$779.01K
derived: sum of 3 quarters · filed 2020-11-12
$973.71K
derived: sum of 4 quarters · filed 2020-11-12
2019-09-30$195.39K
10-Q · filed 2020-11-12
$332.05K
derived: sum of 2 quarters · filed 2020-11-12
$526.76K
derived: sum of 3 quarters · filed 2020-11-12
$654.33K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$136.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06
$331.37K
derived: sum of 2 quarters · filed 2020-10-06
$458.94K
derived: sum of 3 quarters · filed 2020-10-06
$535.50K
10-K · filed 2020-10-06
2019-03-31$194.70K
10-Q · filed 2020-05-15
$322.27K
derived: sum of 2 quarters · filed 2020-05-15
$398.83K
10-Q · filed 2020-05-15
$576.10K
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$127.57K
10-Q · filed 2020-02-14
$204.13K
10-Q · filed 2020-02-14
$381.40K
derived: sum of 3 quarters · filed 2020-02-14
$568.03K
derived: sum of 4 quarters · filed 2020-02-14
2018-09-30$76.56K
10-Q · filed 2019-11-14
$253.83K
derived: sum of 2 quarters · filed 2019-11-14
$440.46K
derived: sum of 3 quarters · filed 2019-11-14
$637.24K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$177.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26
$363.90K
derived: sum of 2 quarters · filed 2019-09-26
$560.68K
derived: sum of 3 quarters · filed 2019-09-26
$749.42K
10-K · filed 2019-09-26
2018-03-31$186.63K
10-Q · filed 2019-05-14
$383.41K
derived: sum of 2 quarters · filed 2019-05-14
$572.15K
10-Q · filed 2019-05-14
$2.22M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$196.78K
10-Q · filed 2019-05-14
$385.53K
10-Q · filed 2019-05-14
$2.04M
derived: sum of 3 quarters · filed 2019-05-14
$2.12M
derived: sum of 4 quarters · filed 2019-05-14
2017-09-30$188.75K
10-Q · filed 2018-11-07
$1.84M
derived: sum of 2 quarters · filed 2018-11-07
$1.92M
derived: sum of 3 quarters · filed 2018-11-07
$2.31M
derived: sum of 4 quarters · filed 2018-11-07
2017-06-30$1.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06
$1.73M
derived: sum of 2 quarters · filed 2018-09-06
$2.12M
derived: sum of 3 quarters · filed 2018-09-06
$2.53M
10-K · filed 2018-09-06
2017-03-31$80.72K
10-Q · filed 2018-05-14
$468.81K
derived: sum of 2 quarters · filed 2018-05-14
$884.19K
10-Q · filed 2018-05-14
$1.95M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31$388.08K
10-Q · filed 2018-02-08
$803.47K
10-Q · filed 2018-02-08
$1.87M
derived: sum of 3 quarters · filed 2018-02-08
$5.94M
derived: sum of 4 quarters · filed 2018-02-08
2016-09-30$415.38K
10-Q · filed 2017-11-09
$1.48M
derived: sum of 2 quarters · filed 2017-11-09
$5.55M
derived: sum of 3 quarters · filed 2017-11-09
$5.79M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31
$5.14M
derived: sum of 2 quarters · filed 2017-08-31
$5.38M
derived: sum of 3 quarters · filed 2017-08-31
$5.49M
10-K · filed 2017-08-31
2016-03-31$4.07M
10-Q · filed 2017-05-11
$4.31M
derived: sum of 2 quarters · filed 2017-05-11
$4.43M
10-Q · filed 2017-05-11
$4.43M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31$240.21K
10-Q · filed 2017-02-09
$353.47K
10-Q · filed 2017-02-09
$357.56K
derived: sum of 3 quarters · filed 2017-02-09
$393.61K
derived: sum of 4 quarters · filed 2017-02-09
2015-09-30$113.25K
10-Q · filed 2016-11-07
$113.13K
10-Q · filed 2015-11-06
$117.35K
derived: sum of 2 quarters · filed 2016-11-07
$153.40K
derived: sum of 3 quarters · filed 2016-11-07
2015-06-30$4.09K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01
$40.15K
derived: sum of 2 quarters · filed 2016-09-01
$114.99K
10-K · filed 2016-09-01
2015-03-31$36.05K
10-Q · filed 2016-05-11
$110.90K
10-Q · filed 2016-05-11
2015-02-28$474.00
10-Q · filed 2015-04-15
$937.00
10-Q · filed 2015-04-15
2014-12-31$37.55K
10-Q · filed 2016-02-11
$74.85K
10-Q · filed 2016-02-11
2014-11-30$463.00
10-Q · filed 2015-01-12
2014-09-30$37.30K
10-Q · filed 2015-11-06
2014-05-31$692.00
10-Q · filed 2014-07-10
$3.83K
10-Q · filed 2014-07-10
$29.02K
10-Q · filed 2014-07-10
2014-03-31$11.98K
10-Q · filed 2015-05-19
$11.66K
10-Q · filed 2015-05-19
2014-02-28$1.64K
10-Q · filed 2015-04-15
$3.14K
10-Q · filed 2015-04-15
$4.60K
derived: sum of 3 quarters · filed 2015-04-15
$5.91K
derived: sum of 4 quarters · filed 2015-04-15
$28.33K
10-Q · filed 2014-04-11
2013-11-30$1.50K
10-Q · filed 2015-01-12
$2.96K
derived: sum of 2 quarters · filed 2015-01-12
$4.27K
derived: sum of 3 quarters · filed 2015-01-12
$5.38K
derived: sum of 4 quarters · filed 2015-01-12
$26.70K
10-Q · filed 2014-01-10
2013-08-31$1.46K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26
$2.77K
derived: sum of 2 quarters · filed 2014-11-26
$3.88K
derived: sum of 3 quarters · filed 2014-11-26
$4.90K
10-K · filed 2014-11-26
$25.20K
10-K · filed 2014-11-26
2013-05-31$1.31K
10-Q · filed 2014-07-10
$2.42K
derived: sum of 2 quarters · filed 2014-04-11
$3.44K
10-Q · filed 2014-07-10
$4.26K
derived: sum of 4 quarters · filed 2014-11-26
$23.73K
10-Q · filed 2013-06-28
2013-02-28$1.11K
10-Q · filed 2014-04-11
$2.13K
10-Q · filed 2014-04-11
$2.95K
derived: sum of 3 quarters · filed 2014-11-26
$3.81K
derived: sum of 4 quarters · filed 2014-11-26
$22.43K
10-Q · filed 2013-04-15
2012-11-30$1.03K
10-Q · filed 2014-01-10
$1.84K
derived: sum of 2 quarters · filed 2014-11-26
$2.70K
derived: sum of 3 quarters · filed 2014-11-26
$3.55K
derived: sum of 4 quarters · filed 2014-11-26
$21.32K
10-Q · filed 2013-01-14
2012-08-31$817.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26
$1.67K
derived: sum of 2 quarters · filed 2014-11-26
$2.53K
derived: sum of 3 quarters · filed 2014-11-26
$3.32K
10-K · filed 2014-11-26
$20.29K
10-K · filed 2012-11-29
2012-05-31$855.00
10-Q · filed 2012-06-26
$1.71K
derived: sum of 2 quarters · filed 2013-06-28
$2.50K
10-Q · filed 2013-06-28
$19.48K
10-Q · filed 2012-06-26
2012-02-29$856.00
10-Q · filed 2012-04-12
$1.65K
10-Q · filed 2013-04-15
$18.62K
10-Q · filed 2012-04-12
2012-02-28$856.00
10-Q · filed 2013-04-15
$1.65K
derived: sum of 2 quarters · filed 2013-04-15
$2.45K
derived: sum of 3 quarters · filed 2013-04-15
$3.14K
derived: sum of 4 quarters · filed 2013-04-15
2011-11-30$791.00
10-Q · filed 2013-01-14
-$791.00
10-Q · filed 2011-12-23
$1.59K
derived: sum of 2 quarters · filed 2013-01-14
$2.29K
derived: sum of 3 quarters · filed 2013-01-14
$2.81K
derived: sum of 4 quarters · filed 2013-01-14
-$17.76K
10-Q · filed 2011-12-23
2011-08-31$803.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29
$1.50K
derived: sum of 2 quarters · filed 2012-11-29
$2.02K
derived: sum of 3 quarters · filed 2012-11-29
$3.18K
10-K · filed 2012-11-29
2011-05-31$694.00
10-Q · filed 2012-06-26
$1.22K
derived: sum of 2 quarters · filed 2012-06-26
$2.38K
10-Q · filed 2012-06-26
2011-02-28$522.00
10-Q · filed 2012-04-12
$1.69K
10-Q · filed 2012-04-12
2010-11-30-$1.16K
10-Q · filed 2011-12-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77